Skip to main content
Earnings Labs
MannKind Corporation logo

MannKind Corporation (MNKD)

NASDAQ·Healthcare·Biotechnology

$3.89

+3.32%

Mkt Cap $1.26B

Analyst Ratings

Buy

6

Hold

0

Sell

0

Price Target (14 analysts)

$10.00

Range $7.00 – $13.00

Implied Upside

+157.4%

Consensus $10.00 vs current $3.89